• 1
    Brabec V., Leng M. (1993) DNA interstrand cross-links of trans-diamminedichloroplatinum(II) are preferentially formed between guanine and complementary cytosine residues. Proc Natl Acad Sci U S A;90:53455349.
  • 2
    Novakova O., Vrana O., Kiseleva V.I., Brabec V. (1995) DNA interactions of antitumor platinum(IV) complexes. Eur J Biochem;228:616624.
  • 3
    Fourrier L., Brooks P., Malinge J.M. (2003) Binding discrimination of MutS to a set of lesions and compound lesions (base damage and mismatch) reveals its potential role as a cisplatin-damaged DNA sensing protein. J Biol Chem;278:2126721275.
  • 4
    Murray V. (2000) A survey of the sequence-specific interaction of damaging agents with DNA: emphasis on anti-tumour agents. Prog Nucleic Acid Res Mol Biol;63:367415.
  • 5
    Van Holde K.E. (1989) Chromatin. New York: Springer-Verlag.
  • 6
    Luger K., Mäder A.W., Richmond R.K., Sargent D.F., Richmond T.J. (1997) Crystal structure of the nucleosome core particle at 2.8 Å resolution. Nature;389:251260.
  • 7
    Richmond T.J., Davey C.A. (2003) The structure of DNA in the nucleosome core. Nature;423:145150.
  • 8
    Laskey R.A., Earnshaw W.C. (1980) Nucleosome assembly. Nature;286:763767.
  • 9
    Galea A.M., Murray V. (2002) The interaction of cisplatin and analogues with DNA in reconstituted chromatin. Biochim Biophys Acta;1579:142152.
  • 10
    Ponti M., Forrow S.M., Souhami R.L., D’Incalci M., Hartley J.A. (1991) Measurement of the sequence specificity of covalent DNA modification by antineoplastic agents using Taq DNA polymerase. Nucleic Acids Res;19:29292933.
  • 11
    Murray V., Motyka H., England P.R., Wickham G., Lee H.H., Denny W.A., McFadyen W.D. (1992) The use of Taq DNA polymerase to determine the sequence specificity of DNA damage caused by cis-diamminedichloroplatinum(II), acridine-tethered platinum(II) diammine complexes or two analogues. J Biol Chem;267:1880518809.
  • 12
    Denny W.A. (1989) DNA-intercalating agents as antitumour drugs : prospects for future design. Anticancer Drug Des;4:241263.
  • 13
    Fan J.-Y., Valu K.K., Woodgate P.D., Baguley B.C., Denny W.A. (1997) Aniline mustard analogues of the DNA-intercalating agent amsacrine: DNA interaction and biological activity. Anticancer Drug Des;12:181203.
  • 14
    Gourdie T.A., Valu K.K., Gravatt G.L., Boritzki T.J., Baguley B.C., Wakelin L.P., Wilson W.R., Woodgate P.D., Denny W.A. (1990) DNA-directed alkylating agents. 1. Structure-activity relationships for acridine-linked aniline mustards: consequences of varying the reactivity of the mustard. J Med Chem;33:11771186.
  • 15
    Prakash A.S., Denny W.A., Gourdie T.A., Valu K.K., Woodgate P.D., Wakelin L.P.G. (1990) DNA-directed alkylating ligands as potential antitumor agents : sequence specificity of alkylation by DNA-intercalating acridine-linked aniline mustards. Biochemistry;29:97999807.
  • 16
    Valu K.K., Gourdie T.A., Boritzki T.J., Gravatt G.L., Baguley B.C., Wilson W.R., Wakelin L.P., Woodgate P.D., Denny W.A. (1990) DNA-directed alkylating agents. 3. Structure-activity relationships for acridine-linked aniline mustards: consequences of varying the length of the linker chain. J Med Chem;33:30143019.
  • 17
    Temple M.D., McFadyen W.D., Holmes R.J., Denny W.A., Murray V. (2000) Interaction of cisplatin and DNA-targeted 9-aminoacridine platinum complexes with DNA. Biochemistry;39:55935599.
  • 18
    Murray V., Whittaker J., Temple M.D., McFadyen W.D. (1997) Interaction of 11 cisplatin analogues with DNA: characteristic pattern of damage with monofunctional analogues. Biochim Biophys Acta;1354:261271.
  • 19
    Tremethick D.J., Frommer M. (1992) Partial purification, from Xenopus laevis oocytes, of an ATP-dependent activity required for nucleosome spacing in vitro. J Biol Chem;267:1504115048.
  • 20
    Drew H.R., Calladine C.R. (1987) Sequence-specific positioning of core histones on an 860 base-pair DNA. Experiment and theory. J Mol Biol;195:143173.
  • 21
    Murray V. (1989) Improved double-stranded DNA sequencing using the linear polymerase chain reaction. Nucleic Acids Res;17:8889.
  • 22
    Murray V., Martin R.F. (1989) The degree of ultraviolet light damage to DNA containing iododeoxyuridine or bromodeoxyuridine is dependent on the DNA sequence. Nucleic Acids Res;17:26752691.
  • 23
    Mattes W.B., Hartley J.A., Kohn K.W. (1986) DNA sequence selectivity of guanine-N7 alkylation by nitrogen mustards. Nucleic Acids Res;14:29712987.
  • 24
    Temple M.D., Cairns M.J., Denny W.A., Murray V. (1997) Protein-DNA interactions in the human beta-globin locus control region hypersensitive site-2 as revealed by four nitrogen mustards. Nucleic Acids Res;25:32553260.
  • 25
    Temple M.D., Cairns M.J., Kim A., Murray V. (1999) Protein-DNA footprinting of the human epsilon-globin promoter in human intact cells using nitrogen mustard analogues and other DNA-damaging agents. Biochim Biophys Acta;3:245256.
  • 26
    Murray V, Matias C, McFadyen WD, Wickham G. (1996) The influence of linker chain length on the sequence specificity of DNA damage by n-bromoalkylphenanthridinium bromides in plasmid DNA and in intact human cells. Biochim Biophys Acta;1305:7986.
  • 27
    Murray V., Whittaker J., McFadyen W.D. (1998) DNA sequence selectivity of cisplatin analogues in intact human cells. Chem Biol Interact;110:2737.
  • 28
    Murray V., Motyka H., England P.R., Wickham G., Lee H.H., Denny W.A. et al. (1992) An investigation of the sequence-specific interaction of cis-diamminedichloroplatinum(II) and four analogues, including two acridine-tethered complexes, with DNA inside human cells. Biochemistry;31:1181211817.
  • 29
    Angers M., Drouin R., Bachvarova M., Paradis I., Marceau F., Bachvarov D.R. (2000) In vivo protein-DNA interactions at the kinin B(1) receptor gene promoter: no modification on interleukin-1 beta or lipopolysaccharide induction. J Cell Biochem;78:278296.
  • 30
    Haga K., Fujita H., Nomoto M., Sazawa A., Nakagawa K., Harabayashi T., Shinohara N., Takimoto M., Nonomura K., Kuzumaki N. (2004) Gelsolin gene silencing involving unusual hypersensitivities to dimethylsulfate and KMnO4 in vivo footprinting on its promoter region. Int J Cancer;111:873880.
  • 31
    Temple M.D., Recabarren P., McFadyen W.D., Holmes R.J., Denny W.A., Murray V. (2002) The interaction of DNA-targeted 9-aminoacridine-4-carboxamide platinum complexes with DNA in intact human cells. Biochim Biophys Acta;1574:223230.
  • 32
    Moyer R., Marien K., Van Holde K., Bailey G. (1989) Site-specific aflatoxin B1 adduction of sequence-positioned nucleosome core particles. J Biol Chem;264:1222612231.
  • 33
    Smith B.L., MacLeod M.C. (1993) Covalent binding of the carcinogen benzo[a]pyrene diol epoxide to Xenopus laevis 5 S DNA reconstituted into nucleosomes. J Biol Chem;268:2062020629.
  • 34
    Smith B.L., Bauer G.B., Povirk L.F. (1994) DNA damage induced by bleomycin, neocarzinostatin, and melphalan in a precisely positioned nucleosome. Asymmetry in protection at the periphery of nucleosome-bound DNA. J Biol Chem;269:3058730594.
  • 35
    Millard J.T., Spencer R.J., Hopkins P.B. (1998) Effect of nucleosome structure on DNA interstrand cross-linking reactions. Biochemistry;37:52115219.
  • 36
    Ikuta T., Kan Y.W. (1991) In vivo protein–DNA interactions at the beta-globin gene locus. Proc Natl Acad Sci U S A;88:1018810192.
  • 37
    Venter U., Svaren J., Schmitz J., Schmid A., Horz W. (1994) A nucleosome precludes binding of the transcription factor Pho4 in vivo to a critical target site in the PHO5 promoter. EMBO J;13:48484855.
  • 38
    Finta C., Kiss A. (1997) Footprint analysis of the bsp RI DNA methyltransferase–DNA interaction. Nucleic Acids Res;25:28412846.
  • 39
    Braddock P.D., Connors T.A., Jones M., Khokhar A.R., Melzack D.H., Tobe M.L. (1975) Structure and activity relationships of platinum complexes with anti-tumour activity. Chem Biol Interact;11:145161.
  • 40
    Lee H.H., Palmer B.D., Baguley B.C., Chin M., McFadyen W.D., Wickham G., Thorsbourne-Palmer D., Wakelin L.P.G., Denny W.A. (1992) DNA-directed alkylating agents. 5. Acridinecarboxamide derivatives of (1,2-diaminoethane)dichloroplatinum(II). J Med Chem;35:29832987.
  • 41
    Perrin L.C., Prenzler P.D., Cullinane C., Phillips D.R., Denny W.A., McFadyen W.D. (2000) DNA targeted platinum complexes: synthesis, cytotoxicity and DNA interactions of cis-dichloroplatinum(II) complexes tethered to phenazine-1-carboxamides. J Inorg Biochem;81:111117.
  • 42
    Moore C.W. (1988) Internucleosomal cleavage and chromosomal degradation by bleomycin and phleomycin in yeast. Cancer Res;48:68376843.
  • 43
    Ng K.W., Ridgway P., Cohen D.R., Tremethick D.J. (1997) The binding of a Fos/Jun heterodimer can completely disrupt the structure of a nucleosome. EMBO J;16:20722085.
  • 44
    Noll M. (1974) Internal structure of the chromatin subunit. Nucleic Acids Res;1:15731578.
  • 45
    Kim A.R., Murray V. (2001) Chromatin structure at the 3′-boundary of the human beta-globin locus control region hypersensitive site-2. Int J Biochem Cell Biol;33:11831192.
  • 46
    Temple M.D., Freebody J., Murray V. (2004) Genomic and phylogenetic footprinting at the epsilon-globin silencer region in intact human cells. Biochim Biophys Acta;1678:126134.
  • 47
    Temple M.D., Murray V. (2005) Footprinting the ‘essential regulatory region’ of the retinoblastoma gene promoter in intact human cells. Int J Biochem Cell Biol;37:665678.
  • 48
    Grimmond H.E., Beerman T. (1982) Alteration of chromatin structure induced by the binding of adriamycin, daunorubicin and ethidium bromide. Biochem Pharmacol;31:33793386.
  • 49
    McMurray C.T., Van Holde K.E. (1986) Binding of ethidium bromide causes dissociation of the nucleosome core particle. Proc Natl Acad Sci U S A;83:84728476.
  • 50
    Winzeler E.A., Small E.W. (1991) Fluorescence anisotropy decay of ethidium bound to nucleosome core particles. 2. The torsional motion of the DNA is highly constrained and sensitive to pH. Biochemistry;30:53045313.
  • 51
    Yu L., Goldberg I.H., Dedon P.C. (1994) Enediyne-mediated DNA damage in nuclei is modulated at the level of the nucleosome. J Biol Chem;269:41444151.
  • 52
    Krajewski W.A. (1995) Alterations in the internucleosomal DNA helical twist in chromatin of human erythroleukemia cells in vivo influences the chromatin higher-order folding. FEBS Lett;361: 149152.